Gene · 1948
Papers2,853
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,853
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypoxia-Induced Ephrin-B2 Facilitates Proliferation and Induces Glycolytic Metabolism in Cutaneous Squamous Cell Carcinoma by Modulating PKM2/HIF-1α Axis. | Discov Med | 2024 | 39190384 | PubTator, text mining | PubMed |
| Identification and Validation of Prognostic Risk Model for Female-Specific Lung Adenocarcinoma. | Altern Ther Health Med | 2024 | 39038326 | PubTator, text mining | PubMed |
| Osteoclast-derived coupling factors: origins and state-of-play Louis V Avioli lecture, ASBMR 2023. | J Bone Miner Res | 2024 | 38990205 | PubTator, text mining | PubMed |
| Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma. | Oncotarget | 2024 | 38985143 | PubTator, text mining | PubMed |
| Frontiers and future perspectives of neuroimmunology. | Fundam Res | 2024 | 38933499 | PubTator, text mining | PubMed |
| ephrin-B2 promotes nociceptive plasticity and hyperalgesic priming through EphB2-MNK-eIF4E signaling in both mice and humans. | Pharmacol Res | 2024 | 38925462 | PubTator, text mining | PubMed |
| Vascular smooth muscle cells exhibit elevated hypoxia-inducible Factor-1α expression in human blood vessel organoids, influencing osteogenic performance. | Exp Cell Res | 2024 | 38909881 | PubTator, text mining | PubMed |
| Proangiogenic effect and underlying mechanism of holmium oxide nanoparticles: a new biomaterial for tissue engineering. | J Nanobiotechnology | 2024 | 38902755 | PubTator, text mining | PubMed |
| Predictive value of plasma ephrinB2 levels for amputation risk following endovascular revascularization in peripheral artery disease. | PeerJ | 2024 | 38854794 | PubTator, text mining | PubMed |
| Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering. | Int J Cancer | 2024 | 38848494 | PubTator, text mining | PubMed |
| Structural insights into the Langya virus attachment glycoprotein. | Structure | 2024 | 38815575 | PubTator, text mining | PubMed |
| Nipah Virus Neurotropism: Insights into Blood-Brain Barrier Disruption. | J Integr Neurosci | 2024 | 38812392 | PubTator, text mining | PubMed |
| Analysis of Individual Viral Particles by Flow Virometry. | Viruses | 2024 | 38793683 | PubTator, text mining | PubMed |
| Enzyme-Linked Immunosorbent Assay Using Henipavirus-Receptor EphrinB2 and Monoclonal Antibodies for Detecting Nipah and Hendra Viruses. | Viruses | 2024 | 38793674 | PubTator, text mining | PubMed |
| 3D bioprinting of DPSCs with GelMA hydrogel of various concentrations for bone regeneration. | Tissue Cell | 2024 | 38776731 | PubTator, text mining | PubMed |
| Bioengineering methods for vascularizing organoids. | Cell Rep Methods | 2024 | 38759654 | PubTator, text mining | PubMed |
| ED-71 Improves Bone Mass in Ovariectomized Rats by Inhibiting Osteoclastogenesis Through EphrinB2-EphB4-RANKL/OPG Axis. | Drug Des Devel Ther | 2024 | 38716369 | PubTator, text mining | PubMed |
| The Edifice of Vasculature-On-Chips: A Focused Review on the Key Elements and Assembly of Angiogenesis Models. | ACS Biomater Sci Eng | 2024 | 38712543 | PubTator, text mining | PubMed |
| Mechanisms of autoimmune encephalitis. | Curr Opin Neurol | 2024 | 38667756 | PubTator, text mining | PubMed |
| Ephrin B2 (EFNB2) potentially protects against intervertebral disc degeneration through inhibiting nucleus pulposus cell apoptosis. | Arch Biochem Biophys | 2024 | 38636690 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1948/papers?page=8